We are live on ! Find out more
LP

LMR Partners Portfolio holdings

AUM $45.4B
1-Year Est. Return 60.68%
This Fund
S&P 500
This Quarter Est. Return
+7.55%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$4.02B
AUM Growth
-$2.42B
Cap. Flow
-$2.28B
Cap. Flow %
-56.76%
Top 10 Hldgs %
21.33%
Holding
1,191
New
710
Increased
110
Reduced
88
Closed
253

Top Buys

Rank Stock Value
1
PCGU
PG&E Corporation
PCGU
+$80.3M
2
BIDU icon
Baidu
BIDU
+$77.3M
3
CLGX
Corelogic, Inc.
CLGX
+$64.7M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$61.7M
5
WORK
Slack Technologies, Inc.
WORK
+$58.9M

Top Sells

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$216M
2
HSBC icon
HSBC
HSBC
+$77.2M
3
INFY icon
Infosys
INFY
+$33.7M
4
CHL
China Mobile Limited
CHL
+$30.1M
5
BHP icon
BHP
BHP
+$24.7M

Sector Composition

Rank Sector Weight
1 Technology 13.1%
2 Consumer Discretionary 7.45%
3 Communication Services 7.24%
4 Healthcare 6.92%
5 Financials 6.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CND.WS
801
DELISTED
Concord Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
CND.WS
$133K ﹤0.01%
+147,617
New +$198K
SLCRW
802
DELISTED
Silver Crest Acquisition Corporation Warrant
SLCRW
$131K ﹤0.01%
+256,779
New +$160K
BHR
803
Braemar Hotels & Resorts
BHR
$157M
$130K ﹤0.01%
+21,497
New +$126K
MMAT
804
DELISTED
Meta Materials Inc. Common Stock
MMAT
$129K ﹤0.01%
+352
New +$145K
MAACW
805
DELISTED
Montes Archimedes Acquisition Corp. Warrant
MAACW
$128K ﹤0.01%
150,000
– –
OTLK icon
806
Outlook Therapeutics
OTLK
$198M
$124K ﹤0.01%
+2,749
New +$105K
AAC.WS
807
DELISTED
Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AAC.WS
$123K ﹤0.01%
+140,000
New +$126K
SURF
808
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$123K ﹤0.01%
+15,766
New +$158K
NMTR
809
DELISTED
9 Meters Biopharma
NMTR
$123K ﹤0.01%
+5,247
New +$161K
JAGX icon
810
Jaguar Health
JAGX
$4.91M
– –
0
– –
HZN
811
DELISTED
Horizon Global Corporation
HZN
$122K ﹤0.01%
+11,854
New +$114K
SEEL
812
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$120K ﹤0.01%
+6
New +$70K
GOAC.WS
813
DELISTED
GO Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock
GOAC.WS
$120K ﹤0.01%
133,333
– –
KWAC.WS
814
DELISTED
Kingswood Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common
KWAC.WS
$119K ﹤0.01%
+225,000
New +$173K
STGW icon
815
Stagwell
STGW
$1.92B
$117K ﹤0.01%
+37,349
New +$114K
AQB icon
816
AquaBounty Technologies
AQB
$4.63M
$114K ﹤0.01%
+853
New +$147K
CTXR icon
817
Citius Pharmaceuticals
CTXR
$14.2M
$114K ﹤0.01%
+2,558
New +$102K
TRAW icon
818
Traws Pharma
TRAW
$7.92M
$110K ﹤0.01%
+294
New +$111K
THBRW
819
DELISTED
Thunder Bridge Acquisition II, Ltd. Warrants
THBRW
$110K ﹤0.01%
+50,000
New +$145K
CTIC
820
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$110K ﹤0.01%
+37,769
New +$123K
IIAC.WS
821
DELISTED
Investindustrial Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class
IIAC.WS
$109K ﹤0.01%
+133,333
New +$201K
AIV
822
Aimco
AIV
$377M
$104K ﹤0.01%
+16,930
New +$85.8K
MTNB icon
823
Matinas BioPharma
MTNB
$2.13M
$104K ﹤0.01%
+1,986
New +$133K
AVAN.WS
824
DELISTED
Avanti Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AVAN.WS
$104K ﹤0.01%
99,125
-92,125
-48% -$162K
CRHC.WS
825
DELISTED
Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CRHC.WS
$103K ﹤0.01%
85,550
-14,450
-14% -$28.9K
31 32
33
34 35

Similar funds

Wealthfront Advisers
Wealthfront Advisers Palo Alto, California $45.6B AUM 18.83% 1-Year Est. Return
TCI Fund Management
TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return
Zurich Cantonal Bank
Zurich Cantonal Bank Zurich, Switzerland $46B AUM 27.59% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
AS
Akuna Securities Chicago, Illinois $44.1B AUM 15.47% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
TI
Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return

LMR Partners's Q1 2021 Portfolio in Review

As of Q1 2021, LMR Partners held 1,191 positions worth $4.02B, down 38% from $6.44B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

LMR Partners withdrew a net $2.28B in Q1 2021, closing 253 positions and reducing 88 holdings. Its most notable exit was DuPont de Nemours, an estimated $216M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 4.3% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, LMR Partners opened a new position in PG&E Corporation worth $802K.

  • LMR Partners's largest Q1 2021 buy was PG&E Corporation: 700,000 shares worth $802K.
  • LMR Partners added most to Alexion Pharmaceuticals in Q1 2021, an estimated $61.7M increase.
  • LMR Partners's biggest Q1 2021 reduction was HSBC, cutting an estimated $77.2M.
  • LMR Partners fully exited DuPont de Nemours in Q1 2021, selling an estimated $216M.
  • LMR Partners's ten largest holdings make up 21% of its $4.02B portfolio in Q1 2021.
  • LMR Partners opened 710 new positions and closed 253 in Q1 2021.
  • LMR Partners's portfolio value fell 38% quarter-over-quarter to $4.02B.

Based on LMR Partners's 13F filing for Q1 2021, filed 17 May 2021.